На главную
Результаты поиска “Triple negative breast cancer research”
Triple Negative Breast Cancer Treatment
Dr. Lisa Newman, director of the Breast Cancer Program at Henry Ford Health System, discusses Triple Negative Breast Cancer among African American women with host, Dr. Lonnie Joe on Primary Care.
Просмотров: 3883 HenryFordTV
Risk factors for developing triple-negative breast cancer
Breast cancer is the most common cancer in women. Among the 1.67 million women diagnosed each year, 15% are diagnosed with triple-negative breast cancer (TNBC). More common in women under the age of 50, TNBC has limited treatment options and is associated with particularly poor survival rates. Knowing the signs and symptoms of breast cancer is essential for early diagnosis and treatment. For more information on TNBC, visit https://www.roche.com/dam/jcr:83655b8... Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?sub_confirmation=1 Get in touch with us: https://www.roche.com/ https://www.facebook.com/RocheCareers https://www.linkedin.com/company/roche https://twitter.com/roche Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. For more information and insights visit: https://www.roche.com/
Просмотров: 7688 Roche
Cancer Survivor Story - Denille - Stage 4 Triple Negative Breast Cancer
If you want to learn how Denille beat breast cancer, watch this video now. Her doctors gave her a death sentence… so how is she 100% cancer free today? She was a healthy young woman with two children… until she found a lump in her breast. See how Denille struggled as things went from bad to worse - stage 2 to a devastating stage 4 diagnosis. Why she gave up on conventional treatments. And the amazing story of her message from God about what to do. Next you’ll discover which holistic health doctor for breast cancer healed Denille’s cancer. Her remarkable results in only 2 weeks of all natural breast cancer treatment! And she tells the stories of healing miracles she witnessed in other patients with cancer. Find out about alternative breast cancer treatments that worked for Denille and others. They may work for you and your loved ones who are currently fighting cancer, too. If you like this video, please give it a thumbs up and share it with others you love and care about. WATCH MORE INCREDIBLE CANCER SURVIVOR STORIES: http://bit.ly/cancer-survivor-story-yt ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Have you survived a cancer diagnosis and lived to tell about it? We hear so many amazing stories from our readers about how they beat cancer using the very techniques they’ve learned from The Truth About Cancer… and we’d love to hear YOUR story! Sharing these stories brings hope to those who have been diagnosed with or are currently dealing with cancer. So, if you have a personal story to share of your triumph over cancer, please follow this link and tell us all about it: http://bit.ly/your-cancer-survivor-story-yt . Each week we’ll post a new story on our site from the submissions. ----------------------------------------------------------------------------------------------------------- Visit our website: http://bit.ly/official-website-ttac-yt Join TTAC's 1 million FB fans: http://bit.ly/TTAC-Facebook-YT Follow us on PINTEREST: http://bit.ly/TTAC-Pinterest-YT Find us on INSTAGRAM: http://bit.ly/TTAC-Instagram-YT Support our mission by commenting and sharing with your friends and family below. -------------------------------------------------- About The Truth About Cancer -------------------------------------------------- The Truth About Cancer’s mission is to inform, educate, and eradicate the pandemic of cancer in our modern world. Every single day, tens of thousands of people just like you are curing cancer (and/or preventing it) from destroying their bodies. It’s time to take matters into your own hands and educate yourself on real cancer prevention and treatments. It could save your life or the life of someone you love. --------------------------------------- About Ty Bollinger --------------------------------------- Ty Bollinger is a devoted husband, father, a best-selling author, and a Christian. He is also a licensed CPA, health freedom advocate, cancer researcher, former competitive bodybuilder, and author of the best-selling book Cancer - Step Outside the Box, which has sold over 100,000 copies worldwide. After losing his mother and father and several family members to cancer, Ty’s heartbreak and grief coupled with his firm belief that chemotherapy, radiation, and surgery were the NOT the most effective treatments available for cancer patients led him on a path of discovery. He began a quest to learn everything he possibly could about alternative cancer treatments and the medical industry. What he uncovered was shocking. On his journey, he’s interviewed cutting-edge scientists, leading alternative doctors, and groundbreaking researchers to learn about hidden alternative cancer treatments. What he uncovered help to create The Truth About Cancer and its 3 awe-inspiring docu-series: The Quest for The Cures, The Quest For The Cures Continues, and The Truth About Cancer: A Global Quest. Ty has touched the hearts and changed the lives of thousands of people around the world. Ty speaks frequently at conferences, local health group meetings, churches, and guest stars on multiple radio and TV shows and writes for numerous magazines and websites. ----------------------------------------------------------------------------------------------------------- The Truth About Cancer,truth about cancer,the truth about cancer event,ty bollinger,global quest,a global quest,breast cancer survivor story,cancer survivor stories,how to cure cancer naturally,healing cancer naturally,Alternative cancer treatments,cancer survivor story
Просмотров: 16506 The Truth About Cancer
A triple-negative breast cancer survivor's advice to cancer patients
Bree Sandlin was diagnosed with stage 3 triple-negative breast cancer when she was 37-years-old. After a year of treatment that included chemotherapy, surgery and radiation, there is no trace of cancer. Bree gives her advice to others that have been diagnosed with cancer. http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/breast-cancer/index.html
Просмотров: 5740 MD Anderson Cancer Center
Chemo and immunotherapy together may help triple-negative breast cancer patients
New research is bringing hope to women with a hard-to-treat type of breast cancer. A study published over the weekend in the New England Journal of Medicine found that combining chemotherapy with an immunotherapy medicine added up to 10 months of survival time for patients with triple-negative breast cancer. Dr. David Agus joins "CBS This Morning" with more on the research. Subscribe to the "CBS This Morning" Channel HERE: http://bit.ly/1Q0v2hE Watch "CBS This Morning" HERE: http://bit.ly/1T88yAR Watch the latest installment of "Note to Self," only on "CBS This Morning," HERE: http://cbsn.ws/1Sh8XlB Follow "CBS This Morning" on Instagram HERE: http://bit.ly/1Q7NGnY Like "CBS This Morning" on Facebook HERE: http://on.fb.me/1LhtdvI Follow "CBS This Morning" on Twitter HERE: http://bit.ly/1Xj5W3p Follow "CBS This Morning" on Google+ HERE: http://bit.ly/1SIM4I8 Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8 Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B Delivered by Norah O’Donnell and Gayle King, "CBS This Morning" offers a thoughtful, substantive and insightful source of news and information to a daily audience of 3 million viewers. The Emmy Award-winning broadcast presents a mix of daily news, coverage of developing stories of national and global significance, and interviews with leading figures in politics, business and entertainment. Check local listings for "CBS This Morning" broadcast times.
Просмотров: 1329 CBS This Morning
What is triple-negative breast cancer? | Dana-Farber Cancer Institute
Researchers are actively looking for new treatments for triple-negative breast cancer, says Eric Winer, MD, chief of the Division of Women's Cancers at Dana-Farber's Susan F. Smith Center for Women's Cancers. For more information about breast cancer and how it is diagnosed, visit http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Breast-Cancer.aspx?phase=Before_Treatment
Просмотров: 15399 Dana-Farber Cancer Institute
Dr. Arun on Ongoing Research in Triple-Negative Breast Cancer
Banu Arun, MD, professor in the Department of Breast Medical Oncology, Division of Cancer Medicine and Department of Clinical Cancer Prevention, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, discusses ongoing research in triple-negative breast cancer (TNBC).
Просмотров: 111 OncLiveTV
Triple-negative breast cancers, everything you've always wanted to know |  ECP Symposium
Dr. Reis-Filho Surgical Pathologist, Division of Experimental Pathology, Department of Pathology, Memorial Sloan Kettering Cancer Center presents hot topics within triple negative breast cancers, highlighting the current thinking and clinical studies leading to a greater understanding of the disease and how this will ultimately impact the potential of targeted therapy for patients in the future. Watch the video and go to dako.com for more information about cancer diagnostics. http://www.dako.com
Просмотров: 10456 Dako Cancer Diagnostics
Immunotherapy and Triple Negative Breast Cancer - Mayo Clinic
A promising new study from Mayo Clinic, in conjunction with Caris Life Sciences, points to immunotherapy as a possible treatment option for patients with the difficult-to-treat triple negative breast cancer mutation. The study was presented this week at the 50th annual meeting of the American Society of Clinical Oncology in Chicago. "This study may change our ability to treat triple negative breast cancer patients," says Barbara Pockaj, M.D., lead investigator of the study and Mayo Clinic surgeon. "We may have signs that these patients can be treated with immunotherapy. We don't have a lot of options for these patients and this would really expand our options."
Просмотров: 4510 Mayo Clinic
Current treatment landscape of triple negative breast cancer
In this video, Adrian Harris, MD, DPhil, from the University of Oxford, Oxford, UK, compares the roles of platinum-based drugs and taxanes in triple negative breast cancer (TNBC), before discussing the intriguing progression-free survival and overall survival results from a recent study that compared PD-L1 blocking drugs with taxanes. The results are from an early trial and Prof. Harris hopes they will lead to further studies to potentially identify the expression of PD-L1 as a classifier for targeted therapy. This video was recorded at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK.
Просмотров: 14 VJOncology
First immunotherapy success for triple-negative breast cancer
There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer. New research led by Queen Mary University of London and St Bartholomew’s Hospital has shown that by using a combination of immunotherapy and chemotherapy the body’s own immune system can be tuned to attack triple-negative breast cancer, extending survival by up to ten months. Subscribe to the official Queen Mary University of London channel - bringing you breakthrough research findings and enhanced student life, teaching and learning. http://www.youtube.com/QMULOfficial
Просмотров: 408 QMULOfficial
Dr Fiona Simpson - Triple Negative Breast Cancer Research Discovery
Dr Fiona Simpson's research discovery fighting triple negative breast cancer, one of the more difficult breast cancer's to treat. This research is proudly funded by the PA Research Foundation. Find out more about Project Pink at www.projectpink.org.au. Donate to life-saving cancer research and help make pink just a pretty colour again.
Просмотров: 612 PA Research Foundation
Metastatic Breast Cancer Forum 2017, Triple Negative Breast Cancer | Dana-Farber Cancer Institute
At the annual Metastatic Breast Cancer Forum, sponsored by the Susan F. Smith Center for Women’s Cancers and held at Dana-Farber on Oct. 21, Nancy Lin, MD, and Geoffrey Shapiro, MD, PhD, explain advances in triple negative breast cancer: What it is, how it is treated, and what approaches are being tested in clinical trials.
Просмотров: 1152 Dana-Farber Cancer Institute
New Triple Negative Breast Cancer Study Launched
Dr. Kristi Funk announces the launch of a new study for Triple Negative breast cancer patients, using Cynvenio's non-invasive liquid biopsy technology to identify and monitor early signs of metastasis.
Просмотров: 25067 Pink Lotus Power Up
Genomically Directed Therapy for Triple Negative Breast Cancer
Do you have triple negative breast cancer? Did you have pre-operative chemotherapy with residual disease after surgery? You might be eligible for a clinical trial using an FDA-approved drug that is selected based on genetic differences in your tumor, versus the standard approach. Learn more: http://hoosiercancer.org/clinical-trials/trial/bre12-158/
Просмотров: 512 Hoosier Cancer Research Network
Triple Negative Breast Cancer Treatment Implications
Click Here & Get The 15 Breast Cancer Questions To Ask Your Doctor http://www.breastcanceranswers.com/what-breast-cancer-questions-to-ask/# Breast Cancer Answers is a social media show where viewers submit a question and get the answer from an expert. Submit your question now at, http://www.breastcanceranswers.com/ask. This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk.  If you have any concerns about your health, please consult with a physician.
Просмотров: 37007 Breast Cancer Answers®
Triple negative breast cancer Video Abstract 85442
Video abstract of an original research paper "Triple negative breast cancer: an Indian perspective", published in the open access journal Breast Cancer: Targets and Therapy by Akhtar et al. Introduction: Breast cancer is the most common female cancer in the world. Triple negative breast cancer (TNBC) is a recently identified biological variant with aggressive tumor behavior and poor prognosis. Data of hormonal status from the Indian population is scarce due to financial constraints in performing immunohistochemistry evaluation. The present study aims to prospectively analyze receptor status of all breast cancer patients and identify TNBC and compare their clinical profile and short term survival with other non-TNBC group. Materials and methods: All cytologically and histopathologically confirmed cases of carcinoma breast were prospectively enrolled. In a longitudinal study at tertiary care hospital in central India based on the hormonal status, they were further divided into TNBC and other groups. Comparison of risk factors, clinical profile and short-term survival was carried out. Results: A total 85 patients were enrolled and of them 37 (43.7%) were TNBC. On comparing risk factors ie, age, age at menarche, total reproductive age, age at first child birth, and menopausal status – no statistical significance was observed between the TNBC and non-TNBC groups. But on comparison of clinical profile TNBC tumors were significantly large with majority of patients presenting as locally advanced breast cancer (83%). No statistical difference was observed in axillary lymph node status between two groups. TNBC tumors were histologically more aggressive (grade 3) compared to other groups. No statistically significant difference was observed in short term overall survival but all three deaths were observed in the TNBC group only and two local recurrences after surgery were observed in the TNBC group. Conclusion: TNBC forms a large proportion of carcinoma breast patients in a central Indian scenario and needs more research to identify appropriate treatment planning considering aggressive histology and advanced presentation. Read the original research paper here: http://www.dovepress.com/triple-negative-breast-cancer-an-indian-perspective-peer-reviewed-article-BCTT
Просмотров: 767 Dove Medical Press
Neelima Denduluri, MD -- Treatment of Triple Negative Breast Cancer
Neelima Denduluri, MD Treatment of Triple Negative Breast Cancer Oncology Outlook 2018 USA MCI
Просмотров: 127 Mitchell Cancer Institute
Triple negative breast cancer | Dana-Farber Cancer Institute
Nancy Lin, MD, and Geoffrey Shapiro, MD, PhD, explain research and treatment in triple negative breast cancer to attendees at the fifth annual metastatic breast cancer forum for patients and families, held at Dana-Farber on September 24, 2016. Learn more about Dana=Farber’s program for patients with metastatic breast cancer at http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Breast-Cancer-Treatment-Center/Metastatic-Breast-Cancer-Expertise.aspx
Просмотров: 973 Dana-Farber Cancer Institute
Triple-Negative Breast Cancer Survivor Tanya Hall
After her diagnosis with triple-negative breast cancer, Tanya Hall has undergone a series of treatments. She credits cancer research for the advances that led to her successful treatment. That's why she has joined with the American Association for Cancer Research (AACR) to run in the AACR Rock 'n' Roll Philadelphia Half Marathon on Sept. 18, 2016. Learn how you can join Tanya to support lifesaving cancer research at www.RunnersForResearch.org.
Просмотров: 17448 American Association for Cancer Research
New treatment to triple negative breast cancer
New developments in breast cancer treatment. More info:
Просмотров: 489 João Santos
Triple Negative Breast Cancer Research
Triple Negative Breast Cancer Research
Просмотров: 32 CBS 42
Proposed Clinical Trial Could Change Triple Negative Breast Cancer Treatment
Triple-negative breast cancer is a moniker give to a particularly aggressive group of breast cancers that often affect younger women. Because triple-negative breast cancers are not homogenous, and every single patient responds differently to various chemotherapies, it’s difficult to predict which chemotherapy will best treat each patient's cancer. But the researchers at the UK Markey Cancer Center are working to change that paradigm. Markey’s Breast Translational Group is currently developing a proposed clinical trial that could take the guesswork out of prescribing the second round of chemotherapy by treating a set of animal model “avatars” with the different therapies to gauge the response. To donate to help Markey get this clinical trial started, go to ukmarkey.org/donate and select “Tribute Gift.”
Просмотров: 1571 University of Kentucky
Triple-negative Breast Cancer Clinical Trial Calling for Participants
An ongoing research program, led by Edith Mitchell, M.D., FACP, Clinical Professor of Medicine and Clinical Oncology at the Kimmel Cancer Center at Jefferson and Hallgeir Rui, M.D., Ph.D., Professor of Cancer Biology, has initiated a new clinical trial at the Kimmel Cancer Center at Thomas Jefferson University that offers a more customized and personalized approach to the treatment of triple-negative breast cancer. The trial, with lead investigators Drs. Tiffany Avery in the Department of Medical Oncology and Adam Berger in the Department of Surgery, offers treatment in the form of chemotherapy paired with a supplemental medication called a "Parp Inhibitor" and is designed to target the breast cancer cells to increase response to treatment and decrease the risk of recurrence. Researchers will conduct a randomized two-arm trial in 12-week cycles by administering different types of medicines in addition to chemotherapy. Triple-negative breast cancer cells lack estrogen receptors and progesterone receptors, and do not have an excess of the HER2 protein on their surfaces. This type of breast cancer diagnosis is more prevalent in younger women and in African-American women. Triple-negative breast cancers tend to grow faster and more aggressively and spread to other parts of the body more quicker than most other types of breast cancer. Drs. Mitchell and Rui and their team of researchers are hoping to increase the efficiency and effectiveness of treatment for triple-negative breast cancer through this clinical trial. If you think you may be a potential candidate for this clinical study, please contact the study coordinator, Melisa Mordenti, at 215-955-8979.
Просмотров: 1214 PABreastCancer
In Focus: Triple Negative Breast Cancer
As many of you know, I was diagnosed with Triple Negative breast cancer. It was not a happy surprise to learn that some patients with this type of cancer have cells that do not respond to treatment.
Просмотров: 12500 JoanLunden
ESMO 2018 Congress: Highlights in metastatic triple negative breast cancer LBA1 PR
Dr. Peter Schmid reports on key results from ESMO 2018 Congress: LBA1_PR: IMpassion130: Results from a global, randomised, double-blind, phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in treatment-naive, locally advanced or metastatic triple-negative breast cancer. Produced by the European Society for Medical Oncology http://www.esmo.org
Просмотров: 2565 European Society for Medical Oncology
Advances In Triple Negative Breast Cancer Treatment
Learn about the most recent research in treating triple-negative breast cancer treatment from medical oncologist David A. Margileth, MD. Click Here & Get The 15 Breast Cancer Questions To Ask Your Doctor http://www.breastcanceranswers.com/what-breast-cancer-questions-to-ask/# Breast Cancer Answers is a social media show where viewers submit a question and get the answer from an expert. Submit your question now at, http://www.breastcanceranswers.com/ask. This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk.  If you have any concerns about your health, please consult with a physician.
Просмотров: 24979 Breast Cancer Answers®
Beating Triple Negative Breast Cancer with Clinical Trial - Lehigh Valley Health Network
When Rochelle Eroh, of Hamburg, PA, was diagnosed with hormone receptor negative and HER2 neu negative (also known as triple negative) breast cancer, she quickly learned this was a more aggressive type of breast cancer. Given her young age and the size of her tumor, Lehigh Valley Health Network medical oncologist, Nicholas Lamparella, DO, provided Rochelle with information regarding a clinical trial for a neo-adjuvant chemotherapy regimen. She received the standard of care Paclitaxel, plus or minus two additional drugs, Carboplatin and Veliparib. In this video, Rochelle, breast cancer surgeon, Lori Alfonse, DO, and Rochelle's clinical trial nurse, Morgan Horton, describe Rochelle's experience and the additional level of care provided as part of the clinical trial. Lehigh Valley Health Network is part of the Memorial Sloan Kettering Cancer Alliance, an initiative to improve the quality of care and outcomes for patients with cancer in community health settings. Innovations at MSK, a world leader in cancer research, brings the latest treatments to community providers - and their patients - at an accelerated pace. For more information, call 610-402-CARE or go to LVHN.org/cancer.
Просмотров: 2696 Lehigh Valley Health Network
Dr. Carey on Treating Triple-Negative Breast Cancer
Lisa A. Carey, MD, professor of medicine, Breast Cancer Research, University of North Carolina, medical director, UNC Breast Center, chief of Hematology/Oncology, physician-in-chief, UNC North Carolina Cancer Hospital, discusses treatment options and challenges in triple-negative breast cancer.
Просмотров: 814 OncLiveTV
Blueberries: A Triple Threat Against Triple-Negative Breast Cancers
City of Hope cancer center researchers and study authors Shiuan Chen, Ph.D., and Lynn Adams, Ph.D. discuss the results of a research study on the effects of blueberries on breast cancer. Chen, research fellow Lynn S. Adams, Ph.D., and their colleagues applied blueberry extracts to TNBC cell cultures and found that blueberry extract not only inhibits proliferation and mobility in TNBC cells, it also led to cell death (apoptosis) at over twice the rate of untreated cells. Chen, Adams and others then tested blueberry extracts effectiveness in laboratory animal models. The researchers found that the blueberry groups TNBC tumor weight was 70 percent lighter than the control group and it also exhibited significantly lower proliferation and higher apoptosis activity. ################ CONNECT WITH US WEBSITE: http://www.cityofhope.org FACEBOOK: http://www.facebook.com/cityofhope TWITTER: http://www.twitter.com/cityofhope YOUTUBE: http://www.youtube.com/cityofhopeonline FLICKR: http://www.flickr.com/cityofhope BLOG: http://breakthroughs.cityofhope.org and MORE: http://www.cityofhope.org/getsocial ################ ABOUT CITY OF HOPE City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope's main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics throughout southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit http://www.cityofhope.org.
Просмотров: 8094 City of Hope
Dana-Farber Facebook Live Webchat: Triple Negative Breast Cancer
On Aug. 1, 2017, Ann Partridge, MD, MPH, Director of the Program for Young Women with Breast Cancer at Dana-Farber Cancer Institute, discussed address advancements in research and treatment for women with triple negative breast cancer on Facebook Live. For more information on how breast cancer is treated at Dana-Farber, visit dana-farber.org/breastcancer.
Просмотров: 952 Dana-Farber Cancer Institute
Gene Expression in Triple Negative Breast Cancer Samples - ASHG 2014
How can triple-negative breast cancer research samples be better characterized? Milan Radovich of Indiana University discusses his work on this important cancer type using the new Ion AmpliSeq™ Transcriptome kit on the Ion Proton System, looking for expression-based gene signatures. Learn more about the new Ion AmpliSeq™ Transcriptome kit: http://www.lifetechnologies.com/us/en/home/life-science/sequencing/next-generation-sequencing/ion-torrent-next-generation-sequencing-workflow/ion-torrent-next-generation-sequencing-select-targets/ampliseq-target-selection/ampliseq-transcriptome.html
Просмотров: 1026 Thermo Fisher Scientific
Triple-Negative Breast Cancer From Every Angle
Hear the latest about triple-negative breast cancer from our guest panelists, including some of the myths surrounding it and the research being done to find new treatments. The panel will also discuss side effects, the unique emotional concerns for people with TNBC and how to find a support system. About Our Panelists Helen L. Coons, PhD, ABPP is a board certified clinical health psychologist with over 25 years of professional experience with women and men with cancer, oncology health care providers and the cancer advocacy community. She routinely provides care to women across the life span with early and advanced breast, gynecologic and other cancer diagnoses before, during and after treatment, as well as women at “high risk” for cancer, and caregivers. Dr. Coons is a member of LBBC’s Medical Advisory Board and the advisory committee for an advanced breast cancer survey for Novartis' oncology division. Linda Cooper, LCSW, OSW-C is a licensed clinical social worker and a certified oncology social worker. She joined Rocky Mountain Cancer Centers in the spring of 2008. Linda has worked as a social worker in oncology and psychiatry services, hospitals and clinics, hospice programs, hospital emergency rooms, and geriatric settings. She is especially committed to working with older adults on their cancer journey and advocating for all cancer patients as they cope with quality of life issues. Moderator Janine E. Guglielmino, MA Senior Director, Programs and Partnerships Living Beyond Breast Cancer
Просмотров: 4532 Living Beyond Breast Cancer
Dr. Adams on Immunotherapy in Triple-Negative Breast Cancer
Sylvia Adams, MD, associate professor, Department of Medicine, director, Clinical Research, Breast Cancer Disease Management Group, New York University Langone’s Perlmutter Cancer Center, discusses immunotherapy in triple-negative breast cancer (TNBC).
Просмотров: 216 OncLiveTV
UK Study Shows Key Enzyme Missing from Triple-Negative Breast Cancer
A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain, providing insight into potential therapeutic targets to treat the aggressive cancer. Zhou's study is unique in that his lab is the only one in the country to specifically study the metabolic process of triple-negative breast cancer cells. Triple-negative breast cancer is the most deadly subtype of breast cancer and has poor clinical outcomes due to the early metastasis of tumor cells, resistance to chemotherapy, and the lack of specific drugs that target it. Produced by Research Communications at the University of Kentucky
Просмотров: 1391 University of Kentucky
Treatment of Metastatic Triple-Negative Breast Cancer
Rita Nanda, MD, assistant professor of Medicine, associate director, Breast Medical Oncology, The University of Chicago Medicine, discusses the treatment of metastatic triple-negative breast cancer (TNBC). Most trials reported today are in metastatic TNBC, but areas that need more attention are HER2+ disease and hormone-refractory hormone-receptor positive breast cancer, said Nanda. Knowledge of the role of immune checkpoint inhibition within these subtypes of breast cancer is needed as well. Nanda is also hoping combination therapy with immune checkpoint inhibitors, vaccines, and other therapies will help to improve the current response rates.
Просмотров: 1253 Targeted Oncology
Immunotherapy for Triple-Negative Breast Cancer
Adam M. Brufsky, MD, PhD, FACP; Hope S. Rugo, MD; Lee Schwartzberg, MD, FACP; Komal Jhaveri, MD, FACP; and Francisco Esteva, MD, PhD, discuss the encouraging early results of clinical trials evaluating the use of checkpoint inhibitors and antibody-drug conjugates for patients with triple-negative breast cancer and the rationale for combining other agents to increase the presence of tumor-infiltrating lymphocytes.
Просмотров: 930 OncLiveTV
Targeting Advanced Triple-Negative Breast Cancer | Dana-Farber Cancer Institute
Slides for this presentation are available on Dana-Farber's Slideshare page: http://www.slideshare.net/DanaFarber/embrace-tnbc-webcast-final-edited For more information on Dana-Farber's Breast Oncology Program, visit this website: http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Breast-Cancer-Treatment-Center.aspx Erica Mayer, MD, MPH, of the Susan F. Smith Center for Women's Cancers at Dana-Farber, discusses triple-negative breast cancer and what makes it different from other forms of breast cancer. Mayer also talks about treatment options for triple-negative breast cancer and what you need to know about clinical trials for the disease.
Просмотров: 463 Dana-Farber Cancer Institute
SMU Research: Women with Triple Negative breast cancer
Groundbreaking research looks at women fighting Triple Negative Breast Cancer — an aggressive subtype striking 10 to 20 percent of women with breast cancer — typically young, African-American/Hispanic, or testing positive for BRCA1 gene mutation, says psychologist Georita Frierson of Southern Methodist University.
Просмотров: 733 SMUVideo
Study Findings: Testosterone and Triple Negative Breast Cancer - Mayo Clinic
Could blocking an androgen ( testosterone) receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at the Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) in Phoenix, Ariz are exploring. Preliminary results of a Mayo Clinic -- TGen collaborative study show the androgen receptor may be a potential target to attack in treating triple negative breast cancer (TNBC). Barbara Pockaj, M.D., a surgical oncologist at the Mayo Clinic in Arizona, discusses the study findings and the next steps in research.
Просмотров: 3855 Mayo Clinic
How a triple-negative breast cancer survivor became cancer-free
Bree Sandlin was diagnosed with stage 3 triple-negative breast cancer when she was 37-years-old. After a year of treatment that included chemotherapy, surgery and radiation, there is no trace of cancer. Bree talks about her journey. http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/breast-cancer/treatment/index.html
Просмотров: 1317 MD Anderson Cancer Center
Case Study: Treating Metastatic Triple-Negative Breast Cancer
In the final case study of the discussion, panelists describe the treatment of a 58 year-old Caucasian woman with metastatic triple-negative breast cancer. To view more from this discussion, visit http://www.onclive.com/peer-exchange/MBC-challenges
Просмотров: 2569 OncLiveTV
Triple Negative Breast Cancer
Filmed on location in Las Vegas during the 21st Annual NOCR Meeting, this webcast is part of a series that provides expert discussions from physicians and researchers from around the USA reviewing current standards of management and analyzing the most important new data that has the potential to modify treatment guidelines. In this presentation, Dr. Ruth O'Regan discusses the latest updates in the treatment of triple negative breast cancer. © 2015 Imedex, LLC.
Просмотров: 828 ImedexCME
Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening
Most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2, a Mayo Clinic-led study has found. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer. The results of the research appear in the Journal of Clinical Oncology. Study author, Dr. Fergus Couch, comments
Просмотров: 849 Mayo Clinic
Dr. O'Shaughnessy on Precision Medicine in Triple Negative Breast Cancer
Joyce O'Shaughnessy, MD, co-chair, breast cancer research, chair breast cancer at Baylor University Medical Center, discusses precision medicine in triple negative breast cancer (TNBC). For TNBC, there is a group of patients who really benefit in the metastatic setting from the use of cisplatin or carboplatin, says O'Shaughnessy. A specific phenotype of those patients—particularly those who recur in other locations, such as the lung or lymph nodes—have a very high Ki-67 and tend to benefit tremendously from platinum-based therapy. Some types of TNBC are a bit more indolent, explains O'Shaughnessy. About 20% of these more slow-growing cancers have the androgen receptor, which is an important detail for oncologists to keep in mind, especially when it comes to clinical trial participation. There are a number of emerging, promising therapies and therapeutic hypotheses that are currently being investigated, and significant progress in this space is expected over the next 5 years, says O'Shaughnessy.
Просмотров: 253 OncLiveTV
Chemotherapy plus durvalumab in triple negative breast cancer
Dr Loibl speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about results from Gepar Nuevo, a trial of anthracycline chemotherapy with durvalumab as a treatment for patients with triple negative breast cancer. She outlines the patient cohort and stratification for the trial, and the pCR findings which fell just short of statistical significance, though ORR rates were statistically significant, with the best outcomes from patients who were 'primed' with durvalumab. Dr Loibl notes some adverse events of special interest.
Просмотров: 134 ecancer
Triple-Negative Breast Cancer May Have New Treatment Option
Breastcancer.org Chief Medical Officer Marisa Weiss, M.D., brings you the latest news from the San Antonio Breast Cancer Symposium in our #SABCS15 video series! A study found that in women with triple-negative breast cancer, adding carboplatin to standard chemotherapy before surgery extended disease-free survival. Click here to learn more: http://www.breastcancer.org/research-news/triple-negative-may-have-new-tx-option.
Просмотров: 410 Breastcancer.org
Comment: Metastatic triple-negative breast cancer responds to immunotherapy
Dr Louis Weiner, (Lombardi Comprehensive Cancer Center, Washington D.C, USA) comments on Prof Leisha Emen's research for ecancertv at AACR 2015, He comments on how patients with triple-negative breast cancer have a worse prognosis than patients with other breast cancer subtypes, and in the United States, there is currently no targeted treatment available. He also discusses high hopes for future treatments with an investigational targeted immunotherapy under development directed at metastatic triple-negative breast cancer.
Просмотров: 885 ecancer
Triple Negative Breast Cancer Awareness Day
There are many types of breast cancer. Triple negative breast cancer is one type that is in need of more research.
Просмотров: 955 ISmileTodayBecause.com